Tolero Pharmaceuticals, Inc.

May 18, 2018

Tolero Pharmaceuticals to Present Clinical Data Evaluating Investigational Agent Alvocidib in Patients with Relapsed Refractory MCL-1 dependent AML at EHA 2018

Oct 05, 2017

Tolero Pharmaceuticals to Deliver Keynote Presentations at the 9th International Conference on Leukemia and Hematologic Oncology

Jun 21, 2017

Tolero Pharmaceuticals to Expand Enrollment of Phase II Study of Alvocidib in MCL-1-Dependent AML into Europe

Jun 15, 2017

Tolero Pharmaceuticals to Present Supportive Preclinical Data for Investigational CDK Inhibitor Alvocidib at European Hematology Association Annual Meeting